Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Accenture
Moodys
Novartis
Teva
Cantor Fitzgerald
Boehringer Ingelheim
Cipla
US Army
Deloitte
Queensland Health

Generated: February 24, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,201,772

« Back to Dashboard

Summary for Patent: 4,201,772
Title: Sterile aqueous solution of a mixture of isomalto-oligosaccharides and its use for parenteral administration to mammals
Abstract:A sterile aqueous solution containing 0.02 to 30 g per 100 ml solution of a mixture of isomalto-oligosaccharides comprising (a) 0-15 percent by weight of isomaltose, (b) 20-65 percent by weight of isomaltotriose, isomaltetraose and isomaltopentaose, each of these oligosaccharides being present in an amount of at least 5 percent by weight and at most 25 percent by weight, (c) 20-65 percent by weight of isomaltohexaose, isomaltoheptaose, isomaltooctaose and isomaltononaose, each of isomaltohexaose and isomaltoheptaose being present in an amount of at least 5 percent by weight and at most 25 percent by weight and the total amount of isomaltooctaose and isomaltononaose being at least 5 percent by weight and at most 25 percent by weight, 0-30 percent by weight of said mixture being isomaltooligosaccharides of 10 to 20 glucose units and 0-10 percent by weight of said mixture being isomaltooligosaccharides of 15 to 20 glucose units, the percentages being calculated on the total weight of the mixture of isomalto-oligosaccharides, and the use of said sterile aqueous solution for parenteral administration to mammals closely prior to or contemporaneously with the parenteral administration of clinical dextran to reduce the risks for adverse effects of the clinical dextran.
Inventor(s): Ingelman; Bjorn G. (Upsala, SE), Richter; Ary W. (Upsala, SE), Granath; Kirsti A. (Upsala, SE)
Assignee: Pharmacia Aktiebolag (Upsala, SE)
Application Number:05/891,106
Patent Claim Types:
see list of patent claims
Use; Formulation; Dosage form;

Drugs Protected by US Patent 4,201,772

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 4,201,772

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom16162/77Apr 19, 1977

International Patents Family Members for US Patent 4,201,772

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria A710179 ➤ Try a Free Trial
Austria 362390 ➤ Try a Free Trial
Austria A268678 ➤ Try a Free Trial
Austria 370114 ➤ Try a Free Trial
Belgium 866092 ➤ Try a Free Trial
Canada 1094452 ➤ Try a Free Trial
Switzerland 641353 ➤ Try a Free Trial
Germany 2815967 ➤ Try a Free Trial
Denmark 169378 ➤ Try a Free Trial
Denmark 158627 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
McKinsey
Moodys
Express Scripts
Merck
UBS
Cerilliant
Fuji
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot